Identify likely non-adherent patients with urine drug monitoring from Ameritox.
Complete the form to the right or call now. 888-494-2165

As opioid use has risen, so has misuse,
diversion and abuse.

With prescription use of opioid pain medications on the rise, it’s important to consider strategies for managing the safety of your patients. That’s why medication monitoring through Ameritox is vital to the pain management you provide. Knowing more information about your patients can help you better manage positive outcomes for your chronic pain patients and your practice.

Chart

Ameritox helps you identify which patients are likely taking their medication as prescribed.

Having better information helps you treat your patients with a higher standard of care.

Most urine drug tests will only tell you whether a drug is present or absent in a patient. The Rx GuardianSM process, now enhanced with Rx Guardian CDSM, uses patented methods and the most comprehensive reference database of adherent pain patients. Patients’ normalized results are compared to the reference database, providing clinicians with added assurance in assessing patients’ pain medication adherence. This information helps you identify if your patient may be:

  • Taking too much opioid medication.
  • Not taking enough opioid medication.
  • Taking illicit drugs.
  • Taking an additional medication prescribed by another provider.
  • Potentially abusing or diverting medication.
  • Taking his or her medications as prescribed.
Don’t take chances with your opioid patients. Trust Ameritox to help you monitor their medication adherence.
Complete the form above.
Or call Ameritox now. 888-494-2165
*Katz, N. & Fanciullo, G. (2002). Role of urine toxicology testing in the management of chronic opioid therapy.
The Clinical Journal of Pain, 18(4), S76-82.